Healthcare Services

Allergy Diagnostics Market Global Report 2026 Market Expected to Record Steady Growth and Approach $13.02 Billion by 2030

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Allergy Diagnostics Market By 2030 Starting From Its 2026 Size?

The allergy diagnostics market has experienced substantial expansion in recent years. Its size is projected to increase from $6.99 billion in 2025 to $7.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market is attributable to factors such as the increasing global prevalence of allergies, the widespread adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, a rising awareness regarding allergy management, and the limited availability of advanced in-vitro kits.

The allergy diagnostics market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $13.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This projected increase during the forecast period stems from factors such as progress in component-resolved diagnostics, the incorporation of automation into allergy testing procedures, escalating investment in discovering new allergens, the proliferation of academic and diagnostic laboratory facilities, and the rising need for customized allergy management. Key developments expected throughout this period encompass an increasing need for precise allergy diagnostics, the expanding acceptance of in-vitro testing approaches, the broadening scope of food and drug allergen assessments, enhanced utilization of ELISA, RAST, and CRD kits, and a heightened emphasis on swift, point-of-care allergy identification methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

What Drivers Are Shaping The Future Growth Of The Allergy Diagnostics Market?

The growing frequency of allergic conditions is expected to drive the expansion of the allergy diagnostics market. This increase in allergy ailments is linked to heightened environmental contamination stemming from vehicle emissions and various industrial activities. An allergic response is defined as an unusual reaction by the immune system when exposed to an allergen. Such conditions encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), food allergies, skin allergies, and allergic asthma. For allergic disorders, the most crucial therapeutic approach involves avoiding the specific allergen. Consequently, an accurate allergy diagnosis becomes vital for successful allergy treatment. For example, data from September 2024, provided by Anaphylaxis UK, a charity based in the UK, indicates that 20% of food allergy incidents happen in educational settings. It was also noted that one in five children affected by food allergies face bullying, and one in five parents experience anxiety ranging from moderate to extreme. Furthermore, almost all parents of children with these allergies show symptoms of post-traumatic stress (PTSS), with the incidence being seven times greater for those whose children rely on adrenaline auto-injectors (AAIs). Therefore, the expanding prevalence of allergic conditions is set to further bolster the growth of the allergic diagnostics market.

Which Segment Categories Define The Allergy Diagnostics Market?

The allergy diagnostics market covered in this report is segmented –

1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

3) By Products: Consumables, Instruments

4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

Subsegments:

1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

What Major Market Trends Are Driving Changes In The Allergy Diagnostics Market?

Leading companies within the allergy diagnostics market are developing novel technologies, including AI-driven allergy component testing platforms, to boost their profitability. An AI-powered allergy component testing platform signifies an advanced technological system that utilizes artificial intelligence (AI) to analyze and interpret allergy testing outcomes. For example, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, unveiled an artificial intelligence (AI)-powered platform for testing allergy components, which is proficient in identifying 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This platform offers valuable understanding for determining and optimizing treatment approaches for an individual’s allergy condition, thereby supporting clinicians in making astute clinical decisions by integrating component-resolved diagnostics (CRD) and artificial intelligence (AI).

Who Are The Top Companies Competing In The Allergy Diagnostics Market?

Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

Read the full allergy diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Allergy Diagnostics Market?

North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allergy Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

allergy treatment global market report

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

allergy immunotherapy global market report

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

immunoglobulin e ige allergy blood tests global market report

https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795